Jefferies Group’s Insmed INSM Stock Holding History

Jefferies Group’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$615K	Buy	+28,550	New	+$685K	0.01%	967
2020 Q2	–	Sell	-7,531	Closed	-$121K	–	1666
2020 Q1	$121K	Sell	7,531 -137,263	-95%	-$3.25M	﹤0.01%	1760
2019 Q4	$3.46M	Buy	144,794 +93,922	+185%	+$1.91M	0.03%	725
2019 Q3	$897K	Sell	50,872 -19,893	-28%	-$384K	0.01%	1575
2019 Q2	$1.81M	Sell	70,765 -17,761	-20%	-$495K	0.01%	972
2019 Q1	$2.57M	Buy	88,526 +13,597	+18%	+$352K	0.02%	776
2018 Q4	$983K	Buy	74,929 +25,754	+52%	+$411K	0.01%	1165
2018 Q3	$994K	Buy	+49,175	New	+$1.11M	0.01%	1329
2018 Q2	–	Sell	-8,965	Closed	-$202K	–	2482
2018 Q1	$202K	Buy	8,965 +1,100	+14%	+$28.9K	﹤0.01%	1975
2017 Q4	$245K	Buy	+7,865	New	+$232K	﹤0.01%	2112
2017 Q2	–	Sell	-41,029	Closed	-$718K	–	2370
2017 Q1	$718K	Buy	+41,029	New	+$633K	0.01%	1433
2014 Q2	–	Sell	-5,528	Closed	-$105K	–	2212
2014 Q1	$105K	Buy	+5,528	New	+$105K	﹤0.01%	1830

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jefferies Group's INSM Position: Q3 2022 in Review

Jefferies Group opened a new position in Insmed (INSM) in Q3 2022: 28,550 shares worth $615K. The stake represents 0.01% of the portfolio and ranks #967 among its holdings. This is a return to the name: Jefferies Group previously reported a position in INSM as recently as Q1 2020.

Jefferies Group first reported a position in INSM in Q1 2014 and has held it in 12 quarters since. The position peaked at $3.46M in Q4 2019. 238 funds tracked by Wall St. Rank hold INSM as of Q3 2022.

Jefferies Group held 28,550 shares of Insmed worth $615K as of Q3 2022.
Insmed was a new Jefferies Group position in Q3 2022.
Insmed made up 0.01% of Jefferies Group's portfolio in Q3 2022, its #967 holding.
Jefferies Group first reported a position in Insmed in Q1 2014 and has held it in 12 quarters since.
Jefferies Group's Insmed position peaked at $3.46M in Q4 2019.
238 funds tracked by Wall St. Rank held Insmed as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.